Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

The purpose of this study was to determine the maximum-tolerated dose of gemcitabine plus mitoxantrone in women with metastatic breast cancer (MBC) and to evaluate activity and toxicity of this combination in a phase II trial. Sixty-three patients with MBC, previously treated with chemotherapy inclu...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Lorusso, V, Crucitta, E, Silvestris, N, Catino, A, Caporusso, L, Mazzei, A, Guida, M, Latorre, A, Sambiasi, D, D'Amico, C, Schittulli, F, Calabrese, P, De Lena, M
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2003
Предметы:
Clinical
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2377160/
https://ncbi.nlm.nih.gov/pubmed/12592360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600780
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы